CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine.
In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.
Company Details
- Founded
- -
- Address
- 3172 Porter Drive, Palo Alto,ca 94304,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cvt.com
- Keywords
- Lead jobs.
- HQ
- Palo Alto, CA
Cv Therapeutics Questions
Cv Therapeutics's website is cvt.com
Cv Therapeutics's LinkedIn profile is https://www.linkedin.com/company/cv-therapeutics
Cv Therapeutics's industry is
Biotechnology Research
Cv Therapeutics's top competitors are
Vividion Therapeutics, Inc.,
Mallinckrodt Pharmaceuticals,
Amgen,
Milestone Pharmaceuticals, Inc.,
Denali Therapeutics,
Corcept Therapeutics,
Gilead Sciences,
Cytokinetics,
Aimmune Therapeutics,
Rani Therapeutics.
Cv Therapeutics's categories are Biotechnology Research
Cv Therapeutics's founding year is 1991
